SINGAPORE (Feb 13): Although Religare is still in the midst of reviewing its latest rating on Manulife US REIT, the research house says it remains upbeat on the REIT’s outlook given how its 4Q16 results exceeded forecasts as the US office market continues to strengthen.

(See also: Manulife US REIT declares FY16 DPU of 3.55 US cents, beating forecast by 4.8%)

In a Monday report, the Religare sales team commends how Manulife US REIT’s portfolio valuation continued to grow by 2.5% since Sept 30 last year, as well as registered an “impressive” 7.2% over the last acquisition cost.

To continue reading,

Sign in to access this Premium article.

Subscription entitlements:

Less than $9 per month
3 Simultaneous logins across all devices
Unlimited access to latest and premium articles
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)

Related Stories

Stay updated with Singapore corporate news stories for FREE

Follow our Telegram | Facebook